As of March 2023 Dynavax Technologies has a market cap of $1.25 Billion. This makes Dynavax Technologies the world's 4312th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $1.25 B | -7.26% |
2022 | $1.35 B | -19.57% |
2021 | $1.68 B | 244.19% |
2020 | $0.49 B | 2.21% |
2019 | $0.47 B | -16.59% |
2018 | $0.57 B | -49.24% |
2017 | $1.13 B | 644.59% |
2016 | $0.15 B | -83.62% |
2015 | $0.92 B | 109.42% |
2014 | $0.44 B | -13.89% |
2013 | $0.51 B | -1.13% |
2012 | $0.52 B | 23.74% |
2011 | $0.42 B | 13.8% |
2010 | $0.36 B | 379.99% |
2009 | $77.07 M | 130.23% |
2008 | $33.47 M | -83.52% |
2007 | $0.20 B | -44.27% |
2006 | $0.36 B | 265.8% |
2005 | $99.66 M | -47.38% |
2004 | $0.18 B |
On Mar 25th, 2023 the market cap of Dynavax Technologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $227.97 B | 18,007.90% | ๐บ๐ธ USA |
![]() Amgen AMGN | $127.10 B | 9,995.55% | ๐บ๐ธ USA |
![]() Biogen BIIB | $39.01 B | 2,998.95% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $99.76 B | 7,824.49% | ๐บ๐ธ USA |
![]() Merck MRK | $266.04 B | 21,031.50% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $210.49 B | 16,619.59% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $70.39 B | 5,491.13% | ๐ฌ๐ง UK |
![]() Agenus
AGEN | $0.49 B | -60.65% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $9.51 B | 655.88% | ๐ฎ๐ฑ Israel |